NAVA Navamedic ASA

1.070USD10.35 NOK · OSL-3.27%Mkt Cap: 25.67M USDP/E: —

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. Its product portfolio includ…

Key Statistics

Company
Market Cap25.67M USD
Enterprise Value39.57M USD
Revenue (TTM)57.51M USD
Gross Profit22.79M USD
Net Income (TTM)-2.43M USD
Revenue/Share2.42 USD
Last Price1.070 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees38
CountryNO
SectorHealthcare
IndustryMedical Distribution
ISINNO0010205966
Valuation
P/E (Trailing)—
P/E (Forward)23.70
PEG1.38
EV/EBITDA8.80
EV/Revenue0.69
P/S0.45
P/B0.86
EPS (TTM)-0.11 USD
EPS (Forward)0.05 USD
52W Range
1.0163% of range2.741
52W High2.741 USD
52W Low1.016 USD
Profitability
Gross Margin38.97%
Oper. Margin-0.20%
EBITDA Margin7.82%
Profit Margin-4.16%
ROE-7.05%
ROA-3.17%
ROIC3.39%
ROCE2.93%
Growth
Revenue Growth-13.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF2.65M USD
CapEx (TTM)246.26K USD
FCF Margin8.10%
FCF Yield18.13%
Net Debt13.88M USD
Net Debt/EBITDA3.09
Net Debt/FCF2.98
Balance Sheet
Debt/Equity0.68
Current Ratio1.45
Quick Ratio0.75
Book Value/Sh1.24 USD
Cash/Share0.21 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateApr 13, 2010
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)2.134 USD
Upside (mean)+99.4%
Target Range2.069 USD – 2.172 USD
2.069+99.4% to mean2.172
# Analysts3
Ownership
Shares Out.23.98M
Float9.97M
Insiders69.50%
Institutions15.36%
Technical
SMA 501.288 (-16.9%)
SMA 2001.728 (-38.1%)
Beta0.25
S&P 52W Chg12.00%
Avg Vol (30d)78.03K
Avg Vol (10d)47.55K
Technical Indicators
RSI (14)35.9
MACD-0.6173
MACD Signal-0.6776
MACD Hist.+0.0603
BB Upper1.386 USD
BB Middle1.151 USD
BB Lower0.9150 USD
BB Width40.96%
ATR (14)0.0516 USD
Vol Ratio (20d)0.31x

About Navamedic (OSL: NAVA)

›

Navamedic (OSL: NAVA) is listed on Oslo Børs, where its shares trade in NOK. It belongs to the Medical Distribution industry, part of the Healthcare sector, and reports about 38 employees.

The shares were at 10.35 NOK on 19 November 2026, down 51.9% over 52 weeks. Its 52-week range is 9.820 NOK to 26.50 NOK: the price is 60.9% below the high and 5.4% above the low.

Its market capitalisation is 248.21M NOK.

Navamedic reports return on equity of -7.0%, an operating margin of -0.2% and revenue down 13.2% year over year.

Its debt exceeds its cash by 134.25M NOK, a debt-to-equity ratio of 0.68. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 3 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 20.63 NOK is 99.4% above the current price. The next earnings report is expected on 12 February 2027.